Roswell Park Cancer Institute


TMA has been designed to facilitate identification of markers differentially expressed in primary mesothelioma lesions as well as metastatic lesions. Samples from 56 patients have been incorporated: 51 patients have tissue cores from the primary lesion only, 2 patients have tissue cores from a metastatic lesion only, 1 patient has tissue cores from both the primary and recurrent lesions, and 2 patients have cores from a recurrent lesion.